BJP S McKay et al. Collingridge GL, Olsen RW, Peters JA, Spedding M (2009). A nomenclature for ligand-gated ion channels. Neuropharmacology 56: 2–5. Crair MC, Malenka RC (1995). A critical period for long-term potentiation at thalamocortical synapses. Nature 375: 325–328. Erreger K, Chen PE, Wyllie DJA, Traynelis SF (2004). Glutamate receptor gating. Crit Rev Neurobiol 16: 187–224. Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ et al. (2007). Subunit-speciﬁc agonist activity at NR2A, NR2B, NR2C, and NR2D containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol 72: 907–920. Farrant M, Feldmeyer D, Takahashi T, Cull-Candy SG (1994). NMDA-receptor channel diversity in the developing cerebellum. Nature 368: 335–339. Fischer G, Mutel V, Trube G, Malherbe P, Kew JNC, Mohacsi E et al. (1997). Ro- 25–6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterisation in vitro. J Pharmacol Exp Ther 283: 1285–1292. Flint AC, Maisch US, Weishaupt JH, Kriegstein AR, Monyer H (1997). NR2A Subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci 17: 2469–2476. Frizelle PA, Chen PE, Wyllie DJA (2006). Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3, 4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: implications for studies of synaptic transmission. Mol Pharmacol 70: 1022–1032. Fujikawa DG, Shinmei SS, Cai B (2000). Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience 98: 41–53. Hardingham GE, Fukunaga Y, Bading H (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 5: 405–414. Hatton CJ, Paoletti P (2005). Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46: 261–274. Hess SD, Daggett LP, Crona J, Deal C, Lu CC, Urrutia A et al. (1996). Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 278: 808–816. Hestrin S (1992). Developmental regulation of NMDA receptor mediated synaptic currents at a central synapse. Nature 357: 686–689. Honer M, Benke D, Laube B, Kuhse J, Heckendorn R, Allgeier H et al. (1998). Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors. J Biol Chem 273: 11158–11163. Johnson JW, Ascher P (1987). Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529–531. Kew JN, Richards JG, Mutel V, Kemp JA (1998). Developmental changes in NMDA receptor glycine afﬁnity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J Neurosci 18: 1935–1943. Kleckner NW, Dingledine R (1988). Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science 241: 835–837. Logan SM, Partridge JG, Matta JA, Buonanno A, Vicini S (2007). Long-lasting NMDA receptor-mediated EPSCs in mouse striatal medium spiny neurons. J Neurophysiol 98: 2693–2704. 936 British Journal of Pharmacology (2012) 166 924–937 Martel MA, Wyllie DJ, Hardingham GE (2009). In developing hippocampal neurons, NR2B-containing NMDA receptors can mediate signalling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158: 334–343. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H et al. (1992). Heteromeric NMDA receptors: molecular and functional distinctions of subtypes. Science 256: 1217–1221. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529–540. Mott DD, Doherty JJ, Zhang S, Washburn MS, Fendley MJ, Lyuboslavsky P et al. (1998). Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition. Nat Neurosci 1: 659–667. Ogden KK, Traynelis SF (2011). New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32: 726–733. Otton HJ, Lawson McLean A, Pannozzo MA, Davies CH, Wyllie DJA (2011). Quantiﬁcation of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs. Neuropharmacology 60: 388–396. Papadia S, Soriano FX, Léveillé F, Martel MA, Dakin KA, Hansen HH et al. (2008). Synaptic NMDA receptor activity boosts intrinsic antioxidant defences. Nat Neurosci 11: 476–487. Rauner C, Köhr G (2011). Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses. J Biol Chem 286: 7558–7566. Rutter AR, Stephenson FA (2000). Coexpression of postsynaptic density-95 protein with NMDA receptors results in enhanced receptor expression together with a decreased sensitivity to L-glutamate. J Neurochem 75: 2501–2510. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY (1994). Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144–147. Soriano FX, Martel MA, Papadia S, Vaslin A, Baxter P, Rickman C et al. (2008). Speciﬁc targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci 28: 10696–10710. Stocca G, Vicini S (1998). Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol 507: 13–24. Sugihara H, Moriyoshi K, Ishri T, Masu M, Nakanishi S (1992). Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem Biophys Res Commun 185: 826–832. Tovar KR, Westbrook GL (1999). The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 19: 4180–4188. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK et al. (2010). Glutamate receptor ion channels: structure, regulation and function. Pharmacol Rev 62: 405–496. Williams K (1993). Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44: 851–859. Wrighton DC, Baker EJ, Chen PE, Wyllie DJA (2008). Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol 586: 211–225.